肿瘤性骨软化症中糖代谢异常及其与磷酸盐稳态缺陷的交互作用
研究纳入20例肿瘤性骨软化症(TIO)患者、20例糖耐量正常者和20例2型糖尿病患者行口服葡萄糖耐量试验。TIO患者中60%(12/20)糖耐量受损、5%(1/20)患2型糖尿病;合并糖代谢异常者行走困难更多、血磷和血钙更低,血磷与60分钟血糖、空腹胰岛素及胰岛素抵抗指数负相关,高FGF23组60分钟血糖更高。
要点
- TIO患者中60%(12/20)糖耐量受损、5%(1/20)合并2型糖尿病。
- 合并糖代谢异常的TIO患者血磷0.43±0.10 vs 0.53±0.10(P=.042)、血钙2.20±0.08 vs 2.30±0.40(P=.001)更低。
- 高FGF23组60分钟血糖10.5[9.3,12.3] vs 低组7.3[6.4,10.1](P=.048)。
核心结论
- TIO患者中糖尿病发生可能由行走困难、低血磷和FGF23水平升高所 predispose,血糖异常可能进一步加重低磷血症。
研究设计与样本
- 纳入20例TIO患者、20例糖耐量正常者和20例2型糖尿病患者,均行口服葡萄糖耐量试验(OGTT),并在OGTT期间监测血磷和FGF23浓度。
主要发现
- TIO患者中60%(12/20)糖耐量受损、5%(1/20)患2型糖尿病;合并糖耐量受损或2型糖尿病者行走困难比例69.2% vs 42.9%。
- 合并糖耐量受损或2型糖尿病的TIO患者血磷0.43±0.10 vs 0.53±0.10(P=.042)、血钙2.20±0.08 vs 2.30±0.40(P=.001),均低于无这些情况的TIO患者。
- 血磷水平与60分钟血糖(P<.001)、空腹血浆胰岛素(P<.05)及胰岛素抵抗稳态模型评估(P<.05)呈负相关。
- 高FGF23组60分钟血糖10.5[9.3,12.3] vs 低FGF23组7.3[6.4,10.1](P=.048)。
- 葡萄糖负荷后,FGF23和血磷水平均呈下降趋势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Phosphate homeostasis was compromised in tumor-induced osteomalacia (TIO) due to increased fibroblast growth factor 23 (FGF23) secretion. Nevertheless, the glucose metabolic profile in TIO patients has not been investigated. OBJECTIVES: This work aimed to clarify the glucose metabolic profiles in TIO patients and explore their interaction with impaired phosphate homeostasis. METHODS: 20 TIO patients, 20 individuals with normal glucose tolerance, and 20 patients with type 2 diabetes mellitus (DM) were enrolled and underwent an oral glucose tolerance test (OGTT). Serum phosphate and FGF23 concentration were monitored during OGTT. RESULTS: In patients with TIO, 60% (12/20) exhibited impaired glucose tolerance (IGT) and 5% (1/20) had type 2 DM. Those with IGT or type 2 DM experienced more ambulatory difficulties (69.2% vs 42.9%), lower phosphate concentrations (0.43 ± 0.10 vs 0.53 ± 0.10, P = .042), and lower calcium concentrations (2.20 ± 0.08 vs 2.30 ± 0.40, P = .001) compared to TIO patients without these conditions. According to correlation analysis, serum phosphate levels were negatively correlated with plasma glucose levels at 60 minutes (P < .001), fasting plasma insulin levels (P < .05), and homeostasis model assessment for insulin resistance (P < .05). Those with high FGF23 levels had a higher glucose level at 60 minutes (10.5 [9.3, 12.3] vs 7.3 [6.4, 10.1], P = .048) than that of low group. After glucose loading, both FGF23 and phosphate levels exhibited a decreasing trend. CONCLUSION: The development of diabetes in TIO patients may be predisposed by ambulatory issues, low phosphate, and elevated FGF23 levels. Dysglycemia might further aggravate hypophosphatemia.
引用
- Zhou R, Jiajue R, Ni X, et al. Glucose Metabolic Abnormalities and Their Interaction With Defective Phosphate Homeostasis in Tumor-induced Osteomalacia. J Clin Endocrinol Metab. 2025. PMID: 39873690. doi:10.1210/clinem/dgae886
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。